| 1 |
25757539 | PI3K/AKT/mTOR pathway is activated after imatinib secondary resistance in gastrointestinal stromal tumors (GISTs). | 2015 Apr |
1 |
| 2 |
17923802 | Symptomatic hypoglycemia during imatinib mesylate in a non-diabetic female patient with gastrointestinal stromal tumor. | 2007 Sep |
1 |
| 3 |
15818402 | Role of poly(ADP-ribose) polymerase activity in imatinib mesylate-induced cell death. | 2005 Jun |
1 |
| 4 |
16166321 | Inhibition of the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway but not the MEK/ERK pathway attenuates laminin-mediated small cell lung cancer cellular survival and resistance to imatinib mesylate or chemotherapy. | 2005 Sep 15 |
1 |
| 5 |
12185586 | Phosphatidylinositol-3 kinase inhibitors enhance the anti-leukemia effect of STI571. | 2002 Aug 29 |
1 |